Clinical Trial

A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants
Protocol Amendment History 3 changes
critical Trial status changed: NOT_YET_RECRUITING → COMPLETED 2026-07-21
critical Trial status changed: RECRUITING → NOT_YET_RECRUITING 2026-05-27
critical Primary endpoint(s) modified 2026-05-27
Trial Details
NCT Number NCT07600762
Lead Sponsor AbbVie
Conditions Healthy Volunteer
Enrollment 12 participants
Start Date 2026-04-21
Primary Completion 2026-06-17 (estimated)
Study Completion 2026-06-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-20